Smith & Nephew SNATS (NYSE:SNN) Raised to “Strong-Buy” at Kepler Capital Markets

Smith & Nephew SNATS (NYSE:SNN) was upgraded by equities researchers at Kepler Capital Markets to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports.

Several other research analysts also recently weighed in on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research note on Wednesday, October 8th. Wall Street Zen lowered shares of Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Smith & Nephew SNATS in a research note on Monday, October 20th. Canaccord Genuity Group reduced their price target on Smith & Nephew SNATS from $36.00 to $34.00 and set a “hold” rating on the stock in a research note on Tuesday, November 11th. Finally, Sanford C. Bernstein set a $37.50 price objective on Smith & Nephew SNATS and gave the stock a “market perform” rating in a report on Tuesday, October 14th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $35.75.

Smith & Nephew SNATS Stock Performance

Smith & Nephew SNATS stock opened at $32.56 on Monday. Smith & Nephew SNATS has a fifty-two week low of $23.69 and a fifty-two week high of $38.79. The stock has a fifty day moving average of $35.79 and a two-hundred day moving average of $33.16. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40.

Institutional Trading of Smith & Nephew SNATS

Several institutional investors have recently made changes to their positions in the stock. NewEdge Advisors LLC increased its holdings in shares of Smith & Nephew SNATS by 4,660.4% during the 3rd quarter. NewEdge Advisors LLC now owns 6,379 shares of the medical equipment provider’s stock worth $231,000 after buying an additional 6,245 shares during the last quarter. XTX Topco Ltd acquired a new stake in Smith & Nephew SNATS during the third quarter worth about $672,000. United Capital Financial Advisors LLC acquired a new stake in Smith & Nephew SNATS during the third quarter worth about $228,000. Tidal Investments LLC purchased a new position in shares of Smith & Nephew SNATS in the 3rd quarter worth about $11,483,000. Finally, Steadfast Capital Management LP acquired a new position in shares of Smith & Nephew SNATS in the 3rd quarter valued at about $6,228,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.